Utilizing computed tomography (CT) guidance, researchers have found that performing a minimally invasive anesthetic injection into the stellate ganglia may help address parosmia due to COVID-19, according to study results that will be presented at the annual Radiological Society of North America (RSNA) conference next week.
One of the more commonly known symptoms of COVID-19 is an altered sense of smell, which may linger for months and possibly years among those with Long COVID. However, an emerging computed tomography (CT)-guided and minimally invasive procedure may provide some relief from this condition referred to as parosmia.
In a recent study, which will be presented next week at annual Radiological Society of North America (RSNA) conference in Chicago, researchers assessed the use of a CT-guided stellate ganglion block to stimulate the regional autonomic nervous system. The cohort was comprised of 54 patients referred from an ear, nose, and throat specialist with at least six months of post-COVID parosmia that failed topical and pharmaceutical treatments.
In follow-up data of the 10-minute minimally invasive procedure for 37 patients, 22 patients had improved symptoms one week after the stellate ganglion injection with 18 of those patients reporting significant improvement at one month, according to the researchers. They also noted a mean improvement of 49 percent in parosmia symptoms at three months.
In follow-up data of the stellate ganglion block injection for 37 patients, 22 patients had improved symptoms one week after the injection with 18 of those patients reporting significant improvement at one month, according to the researchers. (Image courtesy of RSNA.)
"The initial patient had a tremendously positive outcome, almost immediately, with continued improvement to the point of symptom resolution at four weeks," noted Adam C. Zoga, M.D., M.B.A., an associate professor of radiology and vice chair for clinical practice at Thomas Jefferson University in Philadelphia. "We have been surprised at some outcomes, including near 100% resolution of phantosmia in some patients, throughout the trial."
The study authors noted that 26 patients in the cohort returned for a contralateral injection approximately six weeks after the first stellate ganglion injection and conceded that it was not effective for those who reported no symptom relief from the first injection.
However, Dr. Zoga pointed out that 86 percent of patients who did respond to the first injections received additional symptom relief with the contralateral injection.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Chest CT Study Shows Higher Emphysema Risk from Combination of Marijuana and Cigarette Smoking
November 28th 2023People who smoke marijuana and cigarettes have 12 times the risk for centrilobular emphysema than non-smokers, according to new computed tomography (CT) research presented at the annual Radiological Society of North America (RSNA) conference.